血液疾病治療藥的中國市場
市場調查報告書
商品編碼
91227

血液疾病治療藥的中國市場

Blood Disease Drugs Markets in China

出版日期: | 出版商: Asia Market Information & Development Co. | 英文 290 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

本報告提供中國的血液疾病治療藥市場相關調查分析,需求與產業趨勢的預測,及商業環境,提供著市場進入相關的資訊。

目錄

第1章 簡介

  • 調查範圍和調查手法
  • 摘要整理

第2章 商業環境

  • 經濟預測
  • 主要經濟指標
  • 工業生產
  • 人口和勞動力
  • 外國投資
  • 國際貿易
  • 財務和稅金的法規
  • 銀行系統和法規
  • 外匯
  • 稅金和關稅

第3章 血液疾病治療藥產業的評估

  • 血液疾病治療藥產業結構
  • 市場規模
  • 促進市場成長的要素
  • 血液疾病治療藥的銷售量
  • 主要生產設施的場所和銷售量
  • 主要生產者的市場佔有率
  • 人事費用
  • 潛在的參與企業
  • 主要的銷售商
  • 主要的外國投資
  • 技術開發

第4章 血液疾病治療藥的生產和需求

  • 概要
  • 血液疾病治療藥的需求:各地區
  • 血液疾病治療藥的銷售量
  • 貧血治療藥
  • mekobaramin
  • kobamamido
  • 琥珀酸鐵
  • roikogen
  • 嗜中性白血球低下症和無顆粒球症的治療藥
  • 維他命B4
  • bachiroru
  • inosinic acid
  • deoxyribose核?酸
  • 腎上腺皮質荷爾蒙
  • 顆粒細胞增生因子(G-CSF)
  • 白血病治療藥的銷售量
  • 干擾素
  • Imatinib
  • Rituximab
  • pirarubishin
  • hidorokishikanpoteshin
  • 其他的血液疾病治療藥的銷售量
  • 血液疾病治療藥的進口
  • 白血病治療藥的進口
  • 其他的血液疾病治療藥的進口
  • 價格趨勢

第5章 血液疾病治療藥市場預測

  • 血液疾病治療藥市場預測概要
  • 政府的法規
  • 醫療保險產業概要
  • 消費者支出趨勢
  • 東北
  • 北部
  • 東南
  • 中部
  • 西南
  • 西北
  • 人口動態趨勢
  • 醫療產業趨勢
  • 醫院和病床

第6章 行銷策略

  • 中國市場進入概要
  • 中國的流通系統
  • 血液疾病治療藥的流通管道
  • 運輸和貨物的基礎設施
  • 通訊
  • 中國市場進入
  • 授權
  • 專利權
  • 電子商務
  • 公司和現場的代理店
  • 代表辦事處和中國的子公司
  • 完全外資企業

第7章 血液疾病治療藥生產者名錄

  • 血液疾病治療藥生產者的簡介
  • 銷售商,公司
  • 研究機關,協會
Product Code: 805

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Blood Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Blood Disease Drugs by Region
  • Blood Disease Drugs Sales Volume
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Sales Volume
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Imports
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs Imports
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Imports
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Imports
  • Pricing Trends

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

  • Blood Disease Drugs Market Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY

  • Blood Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations
  • ULIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Location
  • Major Blood Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Total Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Major Producer and Their Market Share
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Anemia Treatment Drugs Major Producer and Their Market Share
  • Mecobalamin Major Producer and Their Market Share
  • Cobamamide Major Producer and Their Market Share
  • Ferrous Succinate Major Producer and Their Market Share
  • Leucogen Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Major Producer and Their Market Share
  • Batilol Major Producer and Their Market Share
  • Inosine Major Producer and Their Market Share
  • Deoxyribonucleotide Major Producer and Their Market Share
  • Adrenocortical Hormone Major Producer and Their Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
  • Leukemia Treatment Drugs Major Producer and Their Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Major Producers and Their Market Share
  • Imatinib Mesylate Major Producer and Their Market Share
  • Rituximab Major Producer and Their Market Share
  • Pirarubicin Major Producer and Their Market Share
  • Hydroxycampothecin Major Producer and Their Market Share
  • Blood Disease Drugs Import
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • Leukemia Treatment Drugs Import Volume by Drugs Classification

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

ULIST OF CHARTS

I. NTRODUCTION

  • Blood Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China's Imports and Exports

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Blood Disease Drugs Sales Volume
  • Worldwide Blood Disease Drugs Demand by region
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Mecobalamin Sales Volume and Market Share
  • Cobamamide Sales Volume and Market Share
  • Ferrous Succinate Sales Volume and Market Share
  • Leucogen Sales Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Sales Volume and Market Share
  • Batilol Sales Volume and Market Share
  • Inosine Sales Volume and Market Share
  • Deoxyribonucleotide Sales Volume and Market Share
  • Adrenocortical Hormone Sales Volume and Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Sales Volume and Market Share
  • Leukemia Treatment Drugs Sales Volume and Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Sales Volume and Market Share
  • Imatinib Mesylate Sales Volume and Market Share
  • Rituximab Sales Volume and Market Share
  • Pirarubicin Sales Volume and Market Share
  • Hydroxycampothecin Sales Volume and Market Share
  • Other Blood Disease Drugs Sales volume and Market Share
  • Blood Disease Drugs Import Volume
  • Anemia Import Volume and Market Share
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Mecobalamin Import Volume and Market Share
  • Cobamamide Import Volume and Market Share
  • Ferrous Succinate Import Volume and Market Share
  • Leucogen Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • VitamineB4 Import Volume and Market Share
  • Batilol Import Volume and Market Share
  • Inosine Import Volume and Market Share
  • Deoxyribonucleotide Import Volume and Market Share
  • Adrenocortical Hormone Import Volume and Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Import Volume and Market Share
  • Leukemia Treatment Drugs Import Volume and Market Share
  • Leukemia Treatment Drugs Import Volume by Drugs Classification
  • Interferon Treatment Drugs Import Volume and Market Share
  • Imatinib Mesylate Treatment Drugs Import Volume and Market Share
  • Rituximab Treatment Drugs Import Volume and Market Share
  • Pirarubicin Treatment Drugs Import Volume and Market Share
  • Hydroxycampothecin Treatment Drugs Import Volume and Market Share
  • Other Blood Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel